CFR (Code of Federal Regulations) 18-19

La edición anual del Código de Regulaciones Federales (CFR) es la codificación de las reglas generales y permanentes publicadas en el Registro Federal por los departamentos y agencias del Gobierno Federal de los Estados Unidos de América. El título 21 FOOD and DRUGS de 14 volúmenes individuales, que se actualizan una vez por año calendario. El ciclo de actualización anual es el a partir del 1 de abril. Cada título se divide en capítulos, que generalmente llevan el nombre de la agencia emisora y las áreas regulatorias específicas.

Vista rápida

CFR (Code of Federal Regulations) 21-22

Para todos nuestros clientes estamos tomando ya sus órdenes en preventa del CFR (Code of Federal Regulations) Título 21 Food and Drugs

Partes 1-1,499 Revisado a Junio del 2020 y fecha de entrega Enero del 2021

Y con un 10% de Descuento. Adelántese y asegure su abastecimiento ahora!!!

US, CFR Title 21, Food and Drugs. (Table of Contents per Volume) VOL 1 Chapter I, Subchapter A.- General (Parts 1-99)

 

1.- GENERAL ENFORCEMENT REGULATIONS
2.- GENERAL ADMINISTRATIVE RULINGS AND DECISIONS
3.- PRODUCT JURISDICTION
4.- REGULATION OF COMBINATION PRODUCTS
5.- ORGANIZATION
7.- ENFORCEMENT POLICY
10.- ADMINISTRATIVE PRACTICES AND PROCEDURES
11.- ELECTRONIC RECORDS; ELECTRONIC SIGNATURES
12.- FORMAL EVIDENTIARY PUBLIC HEARING
13.- PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRY
14.- PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE
15.- PUBLIC HEARING BEFORE THE COMMISSIONER
16.- REGULATORY HEARING BEFORE THE FOOD AND DRUG ADMINISTRATION
17.- CIVIL MONEY PENALTIES HEARINGS
19.- STANDARDS OF CONDUCT AND CONFLICTS OF INTEREST
20.- PUBLIC INFORMATION
21.- PROTECTION OF PRIVACY
25.- ENVIRONMENTAL IMPACT CONSIDERATIONS
26,. MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN COMMUNITY
50.- PROTECTION OF HUMAN SUBJECTS
54.- FINANCIAL DISCLOSURE BY CLINICAL INVESTIGATORS
56.- INSTITUTIONAL REVIEW BOARDS
58.- GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES
60.- PATENT TERM RESTORATION
70.- COLOR ADDITIVES
71.- COLOR ADDITIVE PETITIONS
73.- LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION
74.- LISTING OF COLOR ADDITIVES SUBJECT TO CERTIFICATION
80.- COLOR ADDITIVE CERTIFICATION
81.- GENERAL SPECIFICATIONS AND GENERAL RESTRICTIONS FOR PROVISIONAL COLOR ADDITIVES FOR USE IN FOODS, DRUGS, AND COSMETICS
82.- LISTING OF CERTIFIED PROVISIONALLY LISTED COLORS AND SPECIFICATIONS
83-98 [RESERVED]
99.- DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES.

 

VOL 2 Subchapter B.- Food for Human Consumption (Parts 100-169)

100.- GENERAL
101.- FOOD LABELING
102.- COMMON OR USUAL NAME FOR NONSTANDARDIZED FOODS
104.- NUTRITIONAL QUALITY GUIDELINES FOR FOODS
105.- FOODS FOR SPECIAL DIETARY USE
106.- INFANT FORMULA REQUIREMENTS PERTAINING TO CURRENT GOOD MANUFACTURING PRACTICE, QUALITY CONTROL PROCEDURES, QUALITY FACTORS, RECORDS AND REPORTS, AND NOTIFICATIONS
107.- INFANT FORMULA
108.- EMERGENCY PERMIT CONTROL
109.- UNAVOIDABLE CONTAMINANTS IN FOOD FOR HUMAN CONSUMPTION AND FOOD-PACKAGING MATERIAL
110.- CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKING, OR HOLDING HUMAN FOOD
111.- CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS
112.- STANDARDS FOR THE GROWING, HARVESTING, PACKING, AND HOLDING OF PRODUCE FOR HUMAN CONSUMPTION
113.- THERMALLY PROCESSED LOW-ACID FOODS PACKAGED IN HERMETICALLY SEALED CONTAINERS 114.- ACIDIFIED FOODS
115.- SHELL EGGS
117.- CURRENT GOOD MANUFACTURING PRACTICE, HAZARD ANALYSIS, AND RISK-BASED PREVENTIVE CONTROLS FOR HUMAN FOOD
118.- PRODUCTION, STORAGE, AND TRANSPORTATION OF SHELL EGGS
119.- DIETARY SUPPLEMENTS THAT PRESENT A SIGNIFICANT OR UNREASONABLE RISK
120.- HAZARD ANALYSIS AND CRITICAL CONTROL POINT (HACCP) SYSTEMS
121.- MITIGATION STRATEGIES TO PROTECT FOOD AGAINST INTENTIONAL ADULTERATION
123.- FISH AND FISHERY PRODUCTS
129.- PROCESSING AND BOTTLING OF BOTTLED DRINKING WATER
130.- FOOD STANDARDS: GENERAL
131.- MILK AND CREAM
133.- CHEESES AND RELATED CHEESE PRODUCTS
135.- FROZEN DESSERTS
136.- BAKERY PRODUCTS
137.- CEREAL FLOURS AND RELATED PRODUCTS
139.- MACARONI AND NOODLE PRODUCTS
145.- CANNED FRUITS
146.- CANNED FRUIT JUICES
150.- FRUIT BUTTERS, JELLIES, PRESERVES, AND RELATED PRODUCTS
152.- FRUIT PIES
155.- CANNED VEGETABLES

156.- VEGETABLE JUICES
158.- FROZEN VEGETABLES
160.- EGGS AND EGG PRODUCTS
161.- FISH AND SHELLFISH
163.- CACAO PRODUCTS
164.- TREE NUT AND PEANUT PRODUCTS 165.- BEVERAGES
166.- MARGARINE
168.- SWEETENERS AND TABLE SIRUPS 169.- FOOD DRESSINGS AND FLAVORINGS

 

VOL 3 Subchapter B.- Food for Human Consumption Continued (Parts 170-199)

170.- FOOD ADDITIVES
171.- FOOD ADDITIVE PETITIONS
172.- FOOD ADDITIVES PERMITTED FOR DIRECT ADDITION TO FOOD FOR HUMAN CONSUMPTION 173.- SECONDARY DIRECT FOOD ADDITIVES PERMITTED IN FOOD FOR HUMAN CONSUMPTION 174.- FOOD ADDITIVES: GENERAL
175.- INDIRECT FOOD ADDITIVES: ADHESIVES AND COMPONENTS OF COATINGS
176.- INDIRECT FOOD ADDITIVES: PAPER AND PAPERBOARD COMPONENTS
177.- INDIRECT FOOD ADDITIVES: POLYMERS
178.- INDIRECT FOOD ADDITIVES: ADJUVANTS, PRODUCTION AIDS, AND SANITIZERS
179.- IRRADIATION IN THE PRODUCTION, PROCESSING AND HANDLING OF FOOD
180.- FOOD ADDITIVES PERMITTED IN FOOD OR IN CONTACT WITH FOOD ON AN INTERIM BASIS PENDING ADDITIONAL STUDY
181.- PRIOR-SANCTIONED FOOD INGREDIENTS
182.- SUBSTANCES GENERALLY RECOGNIZED AS SAFE
184.- DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE
186.- INDIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE
189.- SUBSTANCES PROHIBITED FROM USE IN HUMAN FOOD
190.- DIETARY SUPPLEMENTS
191-199.- [RESERVED]

 

VOL 4 Subchapter C.- Drugs General (Parts 200-299)

200.- GENERAL
201.- LABELING
202.- PRESCRIPTION DRUG ADVERTISING
203.- PRESCRIPTION DRUG MARKETING
205.- GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS 206.- IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE

207.- REQUIREMENTS FOR FOREIGN AND DOMESTIC ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN DRUGS, INCLUDING DRUGS THAT ARE REGULATED UNDER A BIOLOGICS LICENSE APPLICATION, AND ANIMAL DRUGS, AND THE NATIONAL DRUG CODE
208.- MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS

209.- REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT
210.- CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
211.- CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
212.- CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS 216.- HUMAN DRUG COMPOUNDING
225.- CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS
226.- CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES
250.- SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
290.- CONTROLLED DRUGS
299.- DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES

 

VOL 5 Subchapter D.- Drugs for Human Use (Parts 300-499)

300.- GENERAL
310.- NEW DRUGS
312.- INVESTIGATIONAL NEW DRUG APPLICATION
314.- APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
315.- DIAGNOSTIC RADIOPHARMACEUTICALS
316.- ORPHAN DRUGS
317.- QUALIFYING PATHOGENS
320.- BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS
328.- OVER-THE-COUNTER DRUG PRODUCTS INTENDED FOR ORAL INGESTION THAT CONTAIN ALCOHOL
329.- NONPRESCRIPTION HUMAN DRUG PRODUCTS SUBJECT TO SECTION 760 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT
330.- OVER-THE-COUNTER (OTC) HUMAN DRUGS WHICH ARE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED
331.- ANTACID PRODUCTS FOR OVER-THE-COUNTER (OTC) HUMAN USE
332.- ANTIFLATULENT PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
333.- TOPICAL ANTIMICROBIAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
335.- ANTIDIARRHEAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
336.- ANTIEMETIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
338.- NIGHTTIME SLEEP-AID DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
340.- STIMULANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
341.- COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE

343.- INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEUMATIC DRUG PRODUCTS FOR OVER-THE- COUNTER HUMAN USE
344.- TOPICAL OTIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
346.- ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE

347.- SKIN PROTECTANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
348.- EXTERNAL ANALGESIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
349.- OPHTHALMIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
350.- ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
352.- SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE [STAYED INDEFINITELY] 355.- ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
357.- MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
358.- MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
361.- PRESCRIPTION DRUGS FOR HUMAN USE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED: DRUGS USED IN RESEARCH
369.- INTERPRETATIVE STATEMENTS RE WARNINGS ON DRUGS AND DEVICES FOR OVER-THE- COUNTER SALE
370-499.- [RESERVED]

 

VOL 6 Subchapter E.- Animal Drugs, Feeds and Related Products (Parts 500-599)

500.- GENERAL
501.- ANIMAL FOOD LABELING
502.- COMMON OR USUAL NAMES FOR NONSTANDARDIZED ANIMAL FOODS
507.- CURRENT GOOD MANUFACTURING PRACTICE, HAZARD ANALYSIS, AND RISK-BASED PREVENTIVE CONTROLS FOR FOOD FOR ANIMALS
509.- UNAVOIDABLE CONTAMINANTS IN ANIMAL FOOD AND FOOD-PACKAGING MATERIAL 510.- NEW ANIMAL DRUGS
511.- NEW ANIMAL DRUGS FOR INVESTIGATIONAL USE
514.- NEW ANIMAL DRUG APPLICATIONS
515.- MEDICATED FEED MILL LICENSE
516.- NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES
520.- ORAL DOSAGE FORM NEW ANIMAL DRUGS
522.- IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
524.- OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
526.- INTRAMAMMARY DOSAGE FORM NEW ANIMAL DRUGS
528.- NEW ANIMAL DRUGS IN GENETICALLY ENGINEERED ANIMALS
529.- CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS
530.- EXTRALABEL DRUG USE IN ANIMALS
556.- TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD
558.- NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
564.- [RESERVED]
570.- FOOD ADDITIVES

571.- FOOD ADDITIVE PETITIONS
573.- FOOD ADDITIVES PERMITTED IN FEED AND DRINKING WATER OF ANIMALS
579.- IRRADIATION IN THE PRODUCTION, PROCESSING, AND HANDLING OF ANIMAL FEED AND PET FOOD
582.- SUBSTANCES GENERALLY RECOGNIZED AS SAFE
584.- FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE IN FEED AND DRINKING WATER OF ANIMALS
589.- SUBSTANCES PROHIBITED FROM USE IN ANIMAL FOOD OR FEED
590-599.- [RESERVED]

 

VOL 7 Subchapter F.- Biologics (Parts 600-680)

600.- BIOLOGICAL PRODUCTS: GENERAL
601.- LICENSING
606.- CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS
607.- ESTABLISHMENT REGISTRATION AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS AND LICENSED DEVICES
610.- GENERAL BIOLOGICAL PRODUCTS STANDARDS
630.- REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS INTENDED FOR TRANSFUSION OR FOR FURTHER MANUFACTURING USE
640.- ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS
660.- ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR LABORATORY TESTS
680.- ADDITIONAL STANDARDS FOR MISCELLANEOUS PRODUCTS

Subchapter G.- Cosmetics (Parts 700-799)

SUBCHAPTER G—COSMETICS
700.- GENERAL
701.- COSMETIC LABELING
710.- VOLUNTARY REGISTRATION OF COSMETIC PRODUCT ESTABLISHMENTS
720.- VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS 740.- COSMETIC PRODUCT WARNING STATEMENTS

741-799.- [RESERVED]

 

VOL 8 Subchapter H.- Medical Devices (Parts 800-898)

800.- GENERAL
801.- LABELING
803.- MEDICAL DEVICE REPORTING
806.- MEDICAL DEVICES; REPORTS OF CORRECTIONS AND REMOVALS

807.- ESTABLISHMENT REGISTRATION AND DEVICE LISTING FOR MANUFACTURERS AND INITIAL IMPORTERS OF DEVICES
808.- EXEMPTIONS FROM FEDERAL PREEMPTION OF STATE AND LOCAL MEDICAL DEVICE REQUIREMENTS

809.- IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE 810.- MEDICAL DEVICE RECALL AUTHORITY
812.- INVESTIGATIONAL DEVICE EXEMPTIONS
813.- [RESERVED]

814.- PREMARKET APPROVAL OF MEDICAL DEVICES 820.- QUALITY SYSTEM REGULATION
821.- MEDICAL DEVICE TRACKING REQUIREMENTS 822.- POSTMARKET SURVEILLANCE

830.- UNIQUE DEVICE IDENTIFICATION
860.- MEDICAL DEVICE CLASSIFICATION PROCEDURES
861.- PROCEDURES FOR PERFORMANCE STANDARDS DEVELOPMENT
862.- CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES
864.- HEMATOLOGY AND PATHOLOGY DEVICES
866.- IMMUNOLOGY AND MICROBIOLOGY DEVICES
868.- ANESTHESIOLOGY DEVICES
870.- CARDIOVASCULAR DEVICES
872.- DENTAL DEVICES
874.- EAR, NOSE, AND THROAT DEVICES
876.- GASTROENTEROLOGY-UROLOGY DEVICES
878.- GENERAL AND PLASTIC SURGERY DEVICES
880.- GENERAL HOSPITAL AND PERSONAL USE DEVICES
882.- NEUROLOGICAL DEVICES
884.- OBSTETRICAL AND GYNECOLOGICAL DEVICES
886.- OPHTHALMIC DEVICES
888.- ORTHOPEDIC DEVICES
890.- PHYSICAL MEDICINE DEVICES
892.- RADIOLOGY DEVICES
895.- BANNED DEVICES
898.- PERFORMANCE STANDARD FOR ELECTRODE LEAD WIRES AND PATIENT CABLES

Subchapter I.- Mammography Quality Standards (Parts 900-999)

900.- MAMMOGRAPHY
TOC – TABLE OF CONTENTS

ACCREDITATION
QUALITY STANDARS AND CERTIFICATION STATES AS CERTIFIERS

Subchapter J.- Radiological Health (Parts 1000-1050)

1000.- GENERAL
1002.- RECORDS AND REPORTS
1003.- NOTIFICATION OF DEFECTS OR FAILURE TO COMPLY
1004.- REPURCHASE, REPAIRS, OR REPLACEMENT OF ELECTRONIC PRODUCTS
1005.- IMPORTATION OF ELECTRONIC PRODUCTS
1010.- PERFORMANCE STANDARDS FOR ELECTRONIC PRODUCTS: GENERAL
1020.- PERFORMANCE STANDARDS FOR IONIZING RADIATION EMITTING PRODUCTS
1030.- PERFORMANCE STANDARDS FOR MICROWAVE AND RADIO FREQUENCY EMITTING PRODUCTS 1040.- PERFORMANCE STANDARDS FOR LIGHT-EMITTING PRODUCTS
1050.- PERFORMANCE STANDARDS FOR SONIC, INFRASONIC, AND ULTRASONIC RADIATION-EMITTING PRODUCTS

Subchapter K.- Tobacco Products (Parts 1100-1150)

SUBCHAPTER K—TOBACCO PRODUCTS
1100.- TOBACCO PRODUCTS SUBJECT TO FDA AUTHORITY
1105.- GENERAL
1107.- ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
1140.- CIGARETTES, SMOKELESS TOBACCO, AND COVERED TOBACCO PRODUCTS
1141.- CIGARETTE PACKAGE AND ADVERTISING WARNINGS
1143.- MINIMUM REQUIRED WARNING STATEMENTS
1150.- USER FEES

Subchapter L.- Regulations under Certain other Acts Administered by FDA (Parts 1210-1299)

1210.- REGULATIONS UNDER THE FEDERAL IMPORT MILK ACT
1230.- REGULATIONS UNDER THE FEDERAL CAUSTIC POISON ACT
1240.- CONTROL OF COMMUNICABLE DISEASES
1250.- INTERSTATE CONVEYANCE SANITATION
1251-1269.- [RESERVED]
1270.- HUMAN TISSUE INTENDED FOR TRANSPLANTATION
1271.- HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS 1272-1299.- [RESERVED]

 

VOL 9 Chapter II.- Drug Enforcement Administration, Department of Justice (Parts 1300-1399)

1300.- DEFINITIONS
1301.- REGISTRATION OF MANUFACTURERS, DISTRIBUTORS, AND DISPENSERS OF CONTROLLED SUBSTANCES

1302.- LABELING AND PACKAGING REQUIREMENTS FOR CONTROLLED SUBSTANCES 1303.- QUOTAS
1304.- RECORDS AND REPORTS OF REGISTRANTS
1305.- ORDERS FOR SCHEDULE I AND II CONTROLLED SUBSTANCES

1306.- PRESCRIPTIONS
1307.- MISCELLANEOUS
1308.- SCHEDULES OF CONTROLLED SUBSTANCES
1309.- REGISTRATION OF MANUFACTURERS, DISTRIBUTORS, IMPORTERS AND EXPORTERS OF LIST I CHEMICALS
1310.- RECORDS AND REPORTS OF LISTED CHEMICALS AND CERTAIN MACHINES; IMPORTATION AND EXPORTATION OF CERTAIN MACHINES
1311.- REQUIREMENTS FOR ELECTRONIC ORDERS AND PRESCRIPTIONS
1312.- IMPORTATION AND EXPORTATION OF CONTROLLED SUBSTANCES
1313.- IMPORTATION AND EXPORTATION OF LIST I AND LIST II CHEMICALS
1314.- RETAIL SALE OF SCHEDULED LISTED CHEMICAL PRODUCTS
1315.- IMPORTATION AND PRODUCTION QUOTAS FOR EPHEDRINE, PSEUDOEPHEDRINE, AND PHENYLPROPANOLAMINE
1316.- ADMINISTRATIVE FUNCTIONS, PRACTICES, AND PROCEDURES
1317.- DISPOSAL
1321.- DEA MAILING ADDRESSES
1322-1399.- [RESERVED]

Chapter III.- Office of National Drug Control Policy (Parts 1400-1499)

1400.- [RESERVED]
1401.- PUBLIC AVAILABILITY OF INFORMATION 1402.- MANDATORY DECLASSIFICATION REVIEW 1403-1499.- [RESERVED]

Vista rápida

CFR (Code of Federal Regulations) 22-23

Para todos nuestros clientes estamos tomando ya sus órdenes en preventa del CFR (Code of Federal Regulations) Título 23 Food and Drugs

Partes 1-1,499 Revisado a Junio del 2022 y fecha de entrega Enero del 2023

Y con un 10% de Descuento. Adelántese y asegure su abastecimiento ahora!!!

US, CFR Title 23, Food and Drugs. (Table of Contents per Volume) VOL 1 Chapter I, Subchapter A.- General (Parts 1-99)

 

1.- GENERAL ENFORCEMENT REGULATIONS
2.- GENERAL ADMINISTRATIVE RULINGS AND DECISIONS
3.- PRODUCT JURISDICTION
4.- REGULATION OF COMBINATION PRODUCTS
5.- ORGANIZATION
7.- ENFORCEMENT POLICY
10.- ADMINISTRATIVE PRACTICES AND PROCEDURES
11.- ELECTRONIC RECORDS; ELECTRONIC SIGNATURES
12.- FORMAL EVIDENTIARY PUBLIC HEARING
13.- PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRY
14.- PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE
15.- PUBLIC HEARING BEFORE THE COMMISSIONER
16.- REGULATORY HEARING BEFORE THE FOOD AND DRUG ADMINISTRATION
17.- CIVIL MONEY PENALTIES HEARINGS
19.- STANDARDS OF CONDUCT AND CONFLICTS OF INTEREST
20.- PUBLIC INFORMATION
21.- PROTECTION OF PRIVACY
25.- ENVIRONMENTAL IMPACT CONSIDERATIONS
26,. MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN COMMUNITY
50.- PROTECTION OF HUMAN SUBJECTS
54.- FINANCIAL DISCLOSURE BY CLINICAL INVESTIGATORS
56.- INSTITUTIONAL REVIEW BOARDS
58.- GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES
60.- PATENT TERM RESTORATION
70.- COLOR ADDITIVES
71.- COLOR ADDITIVE PETITIONS
73.- LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION
74.- LISTING OF COLOR ADDITIVES SUBJECT TO CERTIFICATION
80.- COLOR ADDITIVE CERTIFICATION
81.- GENERAL SPECIFICATIONS AND GENERAL RESTRICTIONS FOR PROVISIONAL COLOR ADDITIVES FOR USE IN FOODS, DRUGS, AND COSMETICS
82.- LISTING OF CERTIFIED PROVISIONALLY LISTED COLORS AND SPECIFICATIONS
83-98 [RESERVED]
99.- DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES.

 

VOL 2 Subchapter B.- Food for Human Consumption (Parts 100-169)

100.- GENERAL
101.- FOOD LABELING
102.- COMMON OR USUAL NAME FOR NONSTANDARDIZED FOODS
104.- NUTRITIONAL QUALITY GUIDELINES FOR FOODS
105.- FOODS FOR SPECIAL DIETARY USE
106.- INFANT FORMULA REQUIREMENTS PERTAINING TO CURRENT GOOD MANUFACTURING PRACTICE, QUALITY CONTROL PROCEDURES, QUALITY FACTORS, RECORDS AND REPORTS, AND NOTIFICATIONS
107.- INFANT FORMULA
108.- EMERGENCY PERMIT CONTROL
109.- UNAVOIDABLE CONTAMINANTS IN FOOD FOR HUMAN CONSUMPTION AND FOOD-PACKAGING MATERIAL
110.- CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKING, OR HOLDING HUMAN FOOD
111.- CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS
112.- STANDARDS FOR THE GROWING, HARVESTING, PACKING, AND HOLDING OF PRODUCE FOR HUMAN CONSUMPTION
113.- THERMALLY PROCESSED LOW-ACID FOODS PACKAGED IN HERMETICALLY SEALED CONTAINERS 114.- ACIDIFIED FOODS
115.- SHELL EGGS
117.- CURRENT GOOD MANUFACTURING PRACTICE, HAZARD ANALYSIS, AND RISK-BASED PREVENTIVE CONTROLS FOR HUMAN FOOD
118.- PRODUCTION, STORAGE, AND TRANSPORTATION OF SHELL EGGS
119.- DIETARY SUPPLEMENTS THAT PRESENT A SIGNIFICANT OR UNREASONABLE RISK
120.- HAZARD ANALYSIS AND CRITICAL CONTROL POINT (HACCP) SYSTEMS
121.- MITIGATION STRATEGIES TO PROTECT FOOD AGAINST INTENTIONAL ADULTERATION
123.- FISH AND FISHERY PRODUCTS
129.- PROCESSING AND BOTTLING OF BOTTLED DRINKING WATER
130.- FOOD STANDARDS: GENERAL
131.- MILK AND CREAM
133.- CHEESES AND RELATED CHEESE PRODUCTS
135.- FROZEN DESSERTS
136.- BAKERY PRODUCTS
137.- CEREAL FLOURS AND RELATED PRODUCTS
139.- MACARONI AND NOODLE PRODUCTS
145.- CANNED FRUITS
146.- CANNED FRUIT JUICES
150.- FRUIT BUTTERS, JELLIES, PRESERVES, AND RELATED PRODUCTS
152.- FRUIT PIES
155.- CANNED VEGETABLES

156.- VEGETABLE JUICES
158.- FROZEN VEGETABLES
160.- EGGS AND EGG PRODUCTS
161.- FISH AND SHELLFISH
163.- CACAO PRODUCTS
164.- TREE NUT AND PEANUT PRODUCTS 165.- BEVERAGES
166.- MARGARINE
168.- SWEETENERS AND TABLE SIRUPS 169.- FOOD DRESSINGS AND FLAVORINGS

 

VOL 3 Subchapter B.- Food for Human Consumption Continued (Parts 170-199)

170.- FOOD ADDITIVES
171.- FOOD ADDITIVE PETITIONS
172.- FOOD ADDITIVES PERMITTED FOR DIRECT ADDITION TO FOOD FOR HUMAN CONSUMPTION 173.- SECONDARY DIRECT FOOD ADDITIVES PERMITTED IN FOOD FOR HUMAN CONSUMPTION 174.- FOOD ADDITIVES: GENERAL
175.- INDIRECT FOOD ADDITIVES: ADHESIVES AND COMPONENTS OF COATINGS
176.- INDIRECT FOOD ADDITIVES: PAPER AND PAPERBOARD COMPONENTS
177.- INDIRECT FOOD ADDITIVES: POLYMERS
178.- INDIRECT FOOD ADDITIVES: ADJUVANTS, PRODUCTION AIDS, AND SANITIZERS
179.- IRRADIATION IN THE PRODUCTION, PROCESSING AND HANDLING OF FOOD
180.- FOOD ADDITIVES PERMITTED IN FOOD OR IN CONTACT WITH FOOD ON AN INTERIM BASIS PENDING ADDITIONAL STUDY
181.- PRIOR-SANCTIONED FOOD INGREDIENTS
182.- SUBSTANCES GENERALLY RECOGNIZED AS SAFE
184.- DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE
186.- INDIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE
189.- SUBSTANCES PROHIBITED FROM USE IN HUMAN FOOD
190.- DIETARY SUPPLEMENTS
191-199.- [RESERVED]

 

VOL 4 Subchapter C.- Drugs General (Parts 200-299)

200.- GENERAL
201.- LABELING
202.- PRESCRIPTION DRUG ADVERTISING
203.- PRESCRIPTION DRUG MARKETING
205.- GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS 206.- IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE

207.- REQUIREMENTS FOR FOREIGN AND DOMESTIC ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN DRUGS, INCLUDING DRUGS THAT ARE REGULATED UNDER A BIOLOGICS LICENSE APPLICATION, AND ANIMAL DRUGS, AND THE NATIONAL DRUG CODE
208.- MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS

209.- REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT
210.- CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
211.- CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
212.- CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS 216.- HUMAN DRUG COMPOUNDING
225.- CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS
226.- CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES
250.- SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
290.- CONTROLLED DRUGS
299.- DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES

 

VOL 5 Subchapter D.- Drugs for Human Use (Parts 300-499)

300.- GENERAL
310.- NEW DRUGS
312.- INVESTIGATIONAL NEW DRUG APPLICATION
314.- APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
315.- DIAGNOSTIC RADIOPHARMACEUTICALS
316.- ORPHAN DRUGS
317.- QUALIFYING PATHOGENS
320.- BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS
328.- OVER-THE-COUNTER DRUG PRODUCTS INTENDED FOR ORAL INGESTION THAT CONTAIN ALCOHOL
329.- NONPRESCRIPTION HUMAN DRUG PRODUCTS SUBJECT TO SECTION 760 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT
330.- OVER-THE-COUNTER (OTC) HUMAN DRUGS WHICH ARE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED
331.- ANTACID PRODUCTS FOR OVER-THE-COUNTER (OTC) HUMAN USE
332.- ANTIFLATULENT PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
333.- TOPICAL ANTIMICROBIAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
335.- ANTIDIARRHEAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
336.- ANTIEMETIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
338.- NIGHTTIME SLEEP-AID DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
340.- STIMULANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
341.- COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE

343.- INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEUMATIC DRUG PRODUCTS FOR OVER-THE- COUNTER HUMAN USE
344.- TOPICAL OTIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
346.- ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE

347.- SKIN PROTECTANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
348.- EXTERNAL ANALGESIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
349.- OPHTHALMIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
350.- ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
352.- SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE [STAYED INDEFINITELY] 355.- ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
357.- MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
358.- MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
361.- PRESCRIPTION DRUGS FOR HUMAN USE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED: DRUGS USED IN RESEARCH
369.- INTERPRETATIVE STATEMENTS RE WARNINGS ON DRUGS AND DEVICES FOR OVER-THE- COUNTER SALE
370-499.- [RESERVED]

 

VOL 6 Subchapter E.- Animal Drugs, Feeds and Related Products (Parts 500-599)

500.- GENERAL
501.- ANIMAL FOOD LABELING
502.- COMMON OR USUAL NAMES FOR NONSTANDARDIZED ANIMAL FOODS
507.- CURRENT GOOD MANUFACTURING PRACTICE, HAZARD ANALYSIS, AND RISK-BASED PREVENTIVE CONTROLS FOR FOOD FOR ANIMALS
509.- UNAVOIDABLE CONTAMINANTS IN ANIMAL FOOD AND FOOD-PACKAGING MATERIAL 510.- NEW ANIMAL DRUGS
511.- NEW ANIMAL DRUGS FOR INVESTIGATIONAL USE
514.- NEW ANIMAL DRUG APPLICATIONS
515.- MEDICATED FEED MILL LICENSE
516.- NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES
520.- ORAL DOSAGE FORM NEW ANIMAL DRUGS
522.- IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
524.- OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
526.- INTRAMAMMARY DOSAGE FORM NEW ANIMAL DRUGS
528.- NEW ANIMAL DRUGS IN GENETICALLY ENGINEERED ANIMALS
529.- CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS
530.- EXTRALABEL DRUG USE IN ANIMALS
556.- TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD
558.- NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
564.- [RESERVED]
570.- FOOD ADDITIVES

571.- FOOD ADDITIVE PETITIONS
573.- FOOD ADDITIVES PERMITTED IN FEED AND DRINKING WATER OF ANIMALS
579.- IRRADIATION IN THE PRODUCTION, PROCESSING, AND HANDLING OF ANIMAL FEED AND PET FOOD
582.- SUBSTANCES GENERALLY RECOGNIZED AS SAFE
584.- FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE IN FEED AND DRINKING WATER OF ANIMALS
589.- SUBSTANCES PROHIBITED FROM USE IN ANIMAL FOOD OR FEED
590-599.- [RESERVED]

 

VOL 7 Subchapter F.- Biologics (Parts 600-680)

600.- BIOLOGICAL PRODUCTS: GENERAL
601.- LICENSING
606.- CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS
607.- ESTABLISHMENT REGISTRATION AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS AND LICENSED DEVICES
610.- GENERAL BIOLOGICAL PRODUCTS STANDARDS
630.- REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS INTENDED FOR TRANSFUSION OR FOR FURTHER MANUFACTURING USE
640.- ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS
660.- ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR LABORATORY TESTS
680.- ADDITIONAL STANDARDS FOR MISCELLANEOUS PRODUCTS

Subchapter G.- Cosmetics (Parts 700-799)

SUBCHAPTER G—COSMETICS
700.- GENERAL
701.- COSMETIC LABELING
710.- VOLUNTARY REGISTRATION OF COSMETIC PRODUCT ESTABLISHMENTS
720.- VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS 740.- COSMETIC PRODUCT WARNING STATEMENTS

741-799.- [RESERVED]

 

VOL 8 Subchapter H.- Medical Devices (Parts 800-898)

800.- GENERAL
801.- LABELING
803.- MEDICAL DEVICE REPORTING
806.- MEDICAL DEVICES; REPORTS OF CORRECTIONS AND REMOVALS

807.- ESTABLISHMENT REGISTRATION AND DEVICE LISTING FOR MANUFACTURERS AND INITIAL IMPORTERS OF DEVICES
808.- EXEMPTIONS FROM FEDERAL PREEMPTION OF STATE AND LOCAL MEDICAL DEVICE REQUIREMENTS

809.- IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE 810.- MEDICAL DEVICE RECALL AUTHORITY
812.- INVESTIGATIONAL DEVICE EXEMPTIONS
813.- [RESERVED]

814.- PREMARKET APPROVAL OF MEDICAL DEVICES 820.- QUALITY SYSTEM REGULATION
821.- MEDICAL DEVICE TRACKING REQUIREMENTS 822.- POSTMARKET SURVEILLANCE

830.- UNIQUE DEVICE IDENTIFICATION
860.- MEDICAL DEVICE CLASSIFICATION PROCEDURES
861.- PROCEDURES FOR PERFORMANCE STANDARDS DEVELOPMENT
862.- CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES
864.- HEMATOLOGY AND PATHOLOGY DEVICES
866.- IMMUNOLOGY AND MICROBIOLOGY DEVICES
868.- ANESTHESIOLOGY DEVICES
870.- CARDIOVASCULAR DEVICES
872.- DENTAL DEVICES
874.- EAR, NOSE, AND THROAT DEVICES
876.- GASTROENTEROLOGY-UROLOGY DEVICES
878.- GENERAL AND PLASTIC SURGERY DEVICES
880.- GENERAL HOSPITAL AND PERSONAL USE DEVICES
882.- NEUROLOGICAL DEVICES
884.- OBSTETRICAL AND GYNECOLOGICAL DEVICES
886.- OPHTHALMIC DEVICES
888.- ORTHOPEDIC DEVICES
890.- PHYSICAL MEDICINE DEVICES
892.- RADIOLOGY DEVICES
895.- BANNED DEVICES
898.- PERFORMANCE STANDARD FOR ELECTRODE LEAD WIRES AND PATIENT CABLES

Subchapter I.- Mammography Quality Standards (Parts 900-999)

900.- MAMMOGRAPHY
TOC – TABLE OF CONTENTS

ACCREDITATION
QUALITY STANDARS AND CERTIFICATION STATES AS CERTIFIERS

Subchapter J.- Radiological Health (Parts 1000-1050)

1000.- GENERAL
1002.- RECORDS AND REPORTS
1003.- NOTIFICATION OF DEFECTS OR FAILURE TO COMPLY
1004.- REPURCHASE, REPAIRS, OR REPLACEMENT OF ELECTRONIC PRODUCTS
1005.- IMPORTATION OF ELECTRONIC PRODUCTS
1010.- PERFORMANCE STANDARDS FOR ELECTRONIC PRODUCTS: GENERAL
1020.- PERFORMANCE STANDARDS FOR IONIZING RADIATION EMITTING PRODUCTS
1030.- PERFORMANCE STANDARDS FOR MICROWAVE AND RADIO FREQUENCY EMITTING PRODUCTS 1040.- PERFORMANCE STANDARDS FOR LIGHT-EMITTING PRODUCTS
1050.- PERFORMANCE STANDARDS FOR SONIC, INFRASONIC, AND ULTRASONIC RADIATION-EMITTING PRODUCTS

Subchapter K.- Tobacco Products (Parts 1100-1150)

SUBCHAPTER K—TOBACCO PRODUCTS
1100.- TOBACCO PRODUCTS SUBJECT TO FDA AUTHORITY
1105.- GENERAL
1107.- ESTABLISHMENT REGISTRATION, PRODUCT LISTING, AND SUBSTANTIAL EQUIVALENCE REPORTS
1140.- CIGARETTES, SMOKELESS TOBACCO, AND COVERED TOBACCO PRODUCTS
1141.- CIGARETTE PACKAGE AND ADVERTISING WARNINGS
1143.- MINIMUM REQUIRED WARNING STATEMENTS
1150.- USER FEES

Subchapter L.- Regulations under Certain other Acts Administered by FDA (Parts 1210-1299)

1210.- REGULATIONS UNDER THE FEDERAL IMPORT MILK ACT
1230.- REGULATIONS UNDER THE FEDERAL CAUSTIC POISON ACT
1240.- CONTROL OF COMMUNICABLE DISEASES
1250.- INTERSTATE CONVEYANCE SANITATION
1251-1269.- [RESERVED]
1270.- HUMAN TISSUE INTENDED FOR TRANSPLANTATION
1271.- HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS 1272-1299.- [RESERVED]

 

VOL 9 Chapter II.- Drug Enforcement Administration, Department of Justice (Parts 1300-1399)

1300.- DEFINITIONS
1301.- REGISTRATION OF MANUFACTURERS, DISTRIBUTORS, AND DISPENSERS OF CONTROLLED SUBSTANCES

1302.- LABELING AND PACKAGING REQUIREMENTS FOR CONTROLLED SUBSTANCES 1303.- QUOTAS
1304.- RECORDS AND REPORTS OF REGISTRANTS
1305.- ORDERS FOR SCHEDULE I AND II CONTROLLED SUBSTANCES

1306.- PRESCRIPTIONS
1307.- MISCELLANEOUS
1308.- SCHEDULES OF CONTROLLED SUBSTANCES
1309.- REGISTRATION OF MANUFACTURERS, DISTRIBUTORS, IMPORTERS AND EXPORTERS OF LIST I CHEMICALS
1310.- RECORDS AND REPORTS OF LISTED CHEMICALS AND CERTAIN MACHINES; IMPORTATION AND EXPORTATION OF CERTAIN MACHINES
1311.- REQUIREMENTS FOR ELECTRONIC ORDERS AND PRESCRIPTIONS
1312.- IMPORTATION AND EXPORTATION OF CONTROLLED SUBSTANCES
1313.- IMPORTATION AND EXPORTATION OF LIST I AND LIST II CHEMICALS
1314.- RETAIL SALE OF SCHEDULED LISTED CHEMICAL PRODUCTS
1315.- IMPORTATION AND PRODUCTION QUOTAS FOR EPHEDRINE, PSEUDOEPHEDRINE, AND PHENYLPROPANOLAMINE
1316.- ADMINISTRATIVE FUNCTIONS, PRACTICES, AND PROCEDURES
1317.- DISPOSAL
1321.- DEA MAILING ADDRESSES
1322-1399.- [RESERVED]

Chapter III.- Office of National Drug Control Policy (Parts 1400-1499)

1400.- [RESERVED]
1401.- PUBLIC AVAILABILITY OF INFORMATION 1402.- MANDATORY DECLASSIFICATION REVIEW 1403-1499.- [RESERVED]

Vista rápida

CFR (Code of Federal Regulations) Título 21 Food and Drugs

La edición anual del Código de Regulaciones Federales (CFR) es la codificación de las reglas generales y permanentes publicadas en el Registro Federal por los departamentos y agencias del Gobierno Federal de los Estados Unidos de América. El título 21 FOOD and DRUGS de 14 volúmenes individuales, que se actualizan una vez por año calendario. El ciclo de actualización anual es el a partir del 1 de abril. Cada título se divide en capítulos, que generalmente llevan el nombre de la agencia emisora y las áreas regulatorias específicas.

Vista rápida

CFR (Code of Federal Regulations) Título 21 Food and Drugs 19-20

Para todos nuestros clientes estamos tomando ya sus órdenes en preventa del CFR (Code of Federal Regulations) Título 21 Food and Drugs

Partes 1-1,499 Revisado a Junio del 2019 y fecha de entrega Enero del 2020

Vista rápida

Handbook of CEREAL SCIENCE and TECHNOLOGY

Completely updated and enlarged to three volumes, the second edition of Pharmaceutical Dosage Forms: Parenteral Medications examines every important aspect of sterile drug products. Vol 1 Offers comprehensive coverage of formulation and product development.

 

Vista rápida

Lactic Acid Bacteria

La tesis de Zacarías León describe el desarrollo y la validación de métodos analíticos para estimar los procesos iniciados por absorción percutánea de filtros UV

 

Vista rápida

Oral Drug Absortion

La tesis de Zacarías León describe el desarrollo y la validación de métodos analíticos para estimar los procesos iniciados por absorción percutánea de filtros UV

 

Vista rápida